SSII · SS Innovations International, Inc.
$3.48
+0.06 (+1.75%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited interim condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$691.33M
Shares
200.39M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$42.48M
+105.7%
FY2025
Net Income
-$12.13M
+36.7%
FY2025
Gross Margin
46%
+5.1pp
FY2025
Operating Margin
-19.29%
+72.6pp
FY2025
Diluted EPS
-$0.06
+45.5%
FY2025
Operating Cash Flow
-$18.54M
-95.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $52.4M | $42.48M | $20.65M | $5.88M | $1.44M | — | — | — | — | — | — | |
| $872.19K | $497.55K | $335.22K | $151.5K | $2994 | — | — | — | — | — | — | |
| $27.43M | $22.94M | $12.2M | $5.15M | $1.38M | — | — | — | — | — | — | |
| $24.97M | $19.54M | $8.45M | $725.53K | $60.58K | — | — | — | — | — | — | |
| — | 46% | 40.93% | 12.35% | 4.22% | — | — | — | — | — | — | |
| $5.57M | $3.69M | $2.49M | $1.06M | $987.44K | $1000 | $3000 | $60.87K | $27.13K | $71.17K | $127.58K | |
| $1.65M | — | — | — | $1.24M | $458.8K | $287.74K | $752.02K | $404.19K | $939.64K | $334.92K | |
| $16.96M | $14.85M | $10.16M | $10.06M | $1.94M | — | — | — | — | — | — | |
| $1.28M | $1.08M | $436.01K | $152.74K | $96.58K | $18.79K | $37.43K | $37.7K | $19.46K | $789 | — | |
| $33.25M | $27.74M | $27.43M | $21M | $3.02M | $1.41M | $1.1M | $3.37M | $960.38K | $1.01M | $462.49K | |
| -$8.28M | -$8.19M | -$18.98M | -$20.27M | -$2.96M | — | — | — | — | — | — | |
| — | -19.29% | -91.9% | -345.07% | -206.01% | — | — | — | — | — | — | |
| -$7M | -$7.12M | -$18.54M | -$20.12M | -$2.86M | — | — | — | — | — | — | |
| $1.14M | $1.11M | $973.24K | $523.36K | $162K | — | $1059 | $19.75K | — | $27K | $22.52K | |
| — | $14.7K | — | — | — | — | — | — | — | — | — | |
| $115.38K | $33.09K | -$175.24K | -$604.31K | -$255.29K | -$77.27K | -$21.75K | -$19.74K | $58 | -$26.92K | -$22.49K | |
| — | — | — | — | — | -$77.39K | — | — | — | — | — | |
| — | — | — | — | — | -$77.39K | -$25.33K | — | — | — | — | |
| -$8.16M | -$8.16M | -$19.15M | -$20.88M | -$3.21M | -$1.48M | -$1.12M | -$3.39M | -$960.32K | -$1.04M | -$484.98K | |
| — | $3.97M | — | — | — | — | — | — | — | — | — | |
| -$12.43M | -$12.13M | -$19.15M | -$20.88M | -$3.21M | -$1.48M | -$1.12M | -$3.39M | -$960.32K | -$1.04M | -$484.98K | |
| — | -28.55% | -92.74% | -355.36% | -223.79% | — | — | — | — | — | — | |
| -$26.73M | — | — | -$20.94M | -$5.6M | — | — | — | — | — | — | |
| -$15.6M | -$13.4M | -$19.71M | -$21.13M | -$3.16M | — | — | — | — | — | — | |
| USD/shares | -$0.06 | -$0.06 | -$0.11 | -$0.14 | -$0.03 | -$0.05 | -$0.05 | -$0.16 | — | — | — |
| USD/shares | -$0.06 | -$0.06 | -$0.11 | -$0.14 | -$0.03 | -$0.05 | -$0.05 | -$0.16 | — | — | — |
| shares | — | 190.01M | 170.85M | 144.87M | 128.16M | 28.48M | 23.37M | 21.54M | 20.86M | 19.54M | 18.51M |
| shares | — | 198.7M | 181.2M | 152.07M | 128.16M | 28.48M | 23.37M | 21.54M | 20.86M | 19.54M | 18.51M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.65×
EV/EBIT
—
Peer median 25.25×
P/E (TTM)
—
Peer median 24.50×
Peer medians compare against the 71 similar-size Medical Devices companies (of 139 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| India | $36,790,658 | $19,083,703 | $5,362,814 | $1,436,147,000 |
| Philippines | $2,247,832 | — | — | — |
| Indonesia | $1,015,221 | $595,903 | — | — |
| South America | $1,007,103 | $468,203 | — | — |
| Iraq | $766,256 | — | — | — |
| Cyprus | $522,329 | — | — | — |
| Oman | $85,382 | — | — | — |
| United Arab Emirates | $31,256 | — | — | — |
| Nepal | $18,710 | $501,719 | — | — |
| AED | — | — | $512,500 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| System Sales | $38,353,048 | $19,457,767 | $5,225,777 | $1,394,824 |
| Instruments Sale | $3,183,757 | $942,548 | $647,766 | $41,323 |
| Warranty Sale | $877,033 | $177,518 | — | — |
| Lease Income | $70,909 | $71,695 | — | — |
| Warranty Sales | — | $177,518 | $1,771 | $19,346 |